PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium-Reference-Cited by-同舟云学术

PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium

Published:2016-09 Issue:3 Volume:15 Page:243-249
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Bossé Dominick,Mercer Jamison,Raissouni Soundouss,Dennis Kristopher,Goodwin Rachel,Jiang Di,Powell Erin,Kumar Aalok,Lee-Ying Richard,Price-Hiller Julie,Heng Daniel Y.C.,Tang Patricia A.,MacLean Anthony,Cheung Winson Y.,Vickers Michael M.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference16 articles.

1. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients;Havenga;Eur J Surg Oncol,1999

2. Preoperative versus postoperative chemoradiotherapy for rectal cancer;Sauer;N Engl J Med,2004

3. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer;J Clin Oncol,2012

4. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial;Rodel;Lancet Oncol,2015

5. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial;Hong;Lancet Oncol,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant chemotherapy (CAPOX) alone for low- and intermediate-risk stage II/III rectal cancer: Long-term follow-up of a prospective single-arm study;European Journal of Surgical Oncology;2023-12

2. Do treated rectal tumors appear differently on MRI after chemotherapy versus chemoradiotherapy?;Abdominal Radiology;2023-11-24

3. Comparison of the pathological response to 2 or 4 cycles of neoadjuvant CAPOX in II/III rectal cancer patients with low/intermediate risks: study protocol for a prospective, non-inferior, randomized control trial (COPEC trial);Trials;2023-06-13

4. Diagnostic accuracy of endoscopy in determining rectal tumor proximity to the peritoneal reflection;International Journal of Colorectal Disease;2023-04-25

5. Transanal Conformal Resection Is Associated with a Better Postoperative Anorectal Function Compared with Intersphincteric Resection for Low Rectal Cancer;Indian Journal of Surgery;2023-04-19